Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 6/20 | 0.76 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.76 |
| ▸ | SIRT5 | Q9NXA8 | 3/20 | 0.76 |
| ▸ | SIRT3 | Q9NTG7 | 2/20 | 0.76 |
| ▸ | METAP1 | P53582 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | EP300 | Q09472 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13848496 | 1.00 | SIRT2 (0.76) | SIRT2SIRT1SIRT5SIRT3METAP1 | |
| SCHEMBL1520357 | 0.93 | SIRT2 (0.80) | SIRT2SIRT1SIRT5SIRT3METAP1 | |
| SCHEMBL10134156 | 0.82 | SIRT2 (0.69) | SIRT2SIRT1SIRT5SIRT3METAP1 | |
| SCHEMBL4041531 | 0.82 | SIRT2 (0.69) | SIRT2SIRT1SIRT5SIRT3METAP1 | |
| SCHEMBL4044276 | 0.79 | METAP1 (1.00) | SIRT2SIRT1SIRT5SIRT3METAP1 | |
| SCHEMBL13848519 | 0.79 | METAP1 (1.00) | SIRT2SIRT1SIRT5SIRT3METAP1 | |
| SCHEMBL13848499 | 0.79 | METAP1 (0.69) | SIRT2SIRT1SIRT5SIRT3METAP1 | |
| SCHEMBL15421462 | 0.79 | METAP1 (0.73) | SIRT2SIRT1SIRT5SIRT3METAP1 | |
| SCHEMBL13587000 | 0.79 | SIRT2 (0.69) | SIRT2SIRT1SIRT5SIRT3METAP1 | |
| SCHEMBL30020331 | 0.79 | METAP1 (1.00) | SIRT2SIRT1SIRT5SIRT3METAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1305026-B1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | NOVUSPHARMA SPA (IT) | 2009-05-13 | — | — | EP | disclosed |
| US-20080113993-A1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | VIA ARIOSTO, 23 (IT) | 2008-05-15 | — | — | US | disclosed |
| US-20030229108-A1 | Barbituric acid analogs as therapeutic agents | NOVUSPHARMA S.P.A. (IT) | 2003-12-11 | — | — | US | disclosed |
| EP-1305026-A2 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | Novuspharma S.p.A. (IT) | 2003-05-02 | — | — | EP | disclosed |
| WO-2001093841-A2 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | NOVUSPHARMA S.P.A. (IT) | 2001-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229108-A1 | Barbituric acid analogs as therapeutic agents | HIF1AN, HIF1A, VHL | SIRT2 656/4885SIRT1 166/4885SIRT5 1201/4885 |
| US-20080113993-A1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | HIF1A, HIF1AN, PDGFA | SIRT2 904/4885SIRT1 139/4885SIRT5 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.